Abatacept

Details

Files
Generic Name:
Abatacept
Project Status:
Complete
Therapeutic Area:
Arthritis, Juvenile Idiopathic & Juvenile Rheumatoid
Manufacturer:
Bristol-Myers Squibb Canada
Brand Name:
Orencia
Project Line:
Reimbursement Review
Project Number:
SR0145-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Arthritis, Juvenile Idiopathic & Juvenile Rheumatoid
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: